Integra Connect Logo

Success Stories

Integra Connect transforms data into knowledge so that providers, payers, and life sciences organizations can improve patient outcomes, lower costs, and achieve business goals

Our solutions help
solve your

biggest needs

We are the catalysts for the next generation of value-based precision medicine. We transform data into knowledge so that our partners can improve patient care, embrace scientific advancements, speed-up research, manage costs and deliver innovations for patients.  

 

For specialty care providers and practices, cancer institutions and health systems, payers, and life sciences, this is more than a job: it’s a mission. With Integra Connect, our partners on the road to making it a reality.

Established the industry’s largest footprint into oncology practices focused on value-based care, including work with 5,000+ providers

Generated more than $260M in value-based care revenue and more than $100M in shared savings for practices

Published more than 60 scientific publications focused on precision medicine advancements

Our Success

Practice Administration

“We are proud of our providers' abilities to deliver high-quality cancer care, driven by patient, practice and population level analytics from Integra Connect.”
Ruth Dunn
Executive Director at Oklahoma Cancer Specialists & Research Institute in Tulsa, Oklahoma

Results!

Collected $4.5B+ in revenue for customers with 97-99% net collection rate for practice revenues

Our Success

Value-based Care Contracting

“Elevance Health works with Integra Connect to deliver innovative, digital-first technologies and data-driven insights that will transform healthcare into a more proactive and personalized experience that contributes to better health outcomes.”
Chris Day
Elevance Health Veteran

Results!

Launched the largest commercial and Medicare Advantage alternative payment model for oncology across 15 states


View the Webinar
Icon right

Our Success

Commercial

“Integra Connect’s real-world patient data reaffirms the need to bring genomic testing closer to patients.” 
Garret Hampton
President, Clinical Sequencing and Oncology at Thermo Fisher Scientifi

Results!

The Integra Connect quality research initiative led to improvement in rates of broad biomarker testing and initiation of treatment

View Press Release Icon right

- RESULTS -
28% reduction
 of inpatient utilizations

Achieved consistently high
scores on key quality measures,
some with perfect scores

38% reduction in
end-of-life facility costs
for enrolled patients
"We chose to engage Integra Connect to provide our practice with insights related to clinical considerations, cost drivers, opportunities for improvement and to work with us side by side to ensure our organization meets our value-based care business, operational, and clinical goals."
-
Dr. Sibel Blau
Medical Director at
Northwest Medical Specialties

 

Collected $4.5B+ in revenue for customers with 97-99% net collection rate for practice revenues

 

“We are proud of our providers' abilities to deliver high-quality cancer care, driven by patient, practice and population level analytics from Integra Connect.”
-
Ruth Dunn
Executive Director at
Oklahoma Cancer Specialists & Research Institute in Tulsa, Oklahoma
 
Launched the largest commercial and Medicare Advantage alternative payment model for oncology across 15 states
 

“Elevance Health works with Integra Connect to deliver innovative, digital-first technologies and data-driven insights that will transform healthcare into a more proactive and personalized experience that contributes to better health outcomes.” 

-
Chris Day
Elevance Health Veteran

 

The Integra Connect quality research initiative led to improvement in rates of broad biomarker testing and initiation of treatment

 

“Integra Connect’s real-world patient data reaffirms the need to bring genomic testing closer to patients.” 

-
Garret Hampton
President, Clinical Sequencing and Oncology at
Thermo Fisher Scientific

Let’s Achieve Your Goals

Simplify the move from consensus-based medicine to value-based, precision oncology